remikiren remikiren remikiren is a renin inhibitor under development for the treatment of hypertension (high blood pressure). it was first developed by hoffmann–la roche in 1996. remikirenclinical dataatc codec09xa01 (who) legal statuslegal status investigational identifiers iupac name (2s)-2--n--3-(1h-imidazol-4-yl)propanamide cas number126222-34-2 ypubchem cid6324659drugbankdb00212 ychemspider4884377 yuniilc7fbl96a4keggd09038 ychebichebi:8803chemblchembl31601 ycomptox dashboard (epa)dtxsid60155121 chemical and physical dataformulac33h50n4o6smolar mass630.85 g·mol−13d model (jsmol)interactive image smiles o=s(=o)(c(c)(c)c)c(c(=o)n(c(=o)n(cc1ccccc1)(o)(o)c2cc2)cc3cnc3)cc4ccccc4 inchi inchi=1s/c33h50n4o6s/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39h,5,8-9,12-18,20h2,1-3h3,(h,34,35)(h,36,41)(h,37,40)/t25-,27+,28+,29+,30-/m1/s1 ykey:uxigzrqvlgftou-vqxqmpivsa-n y (verify)